US2022096586A1PendingUtilityA1
Pharmaceutical composition comprising a fraction of melissa officinalis leaf extract
Est. expiryMay 22, 2039(~12.9 yrs left)· nominal 20-yr term from priority
A61P 27/16A61K 2236/51A61K 2236/333A61P 29/00A61K 36/53A61K 2236/00A61K 2236/53A61K 2236/39A61P 15/02
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a pharmaceutical composition for preventing or treating otitis media with effusion comprising a fraction of Melissa officinalis leaf extract as an effective ingredient.
Claims
exact text as granted — not AI-modified1 . A pharmaceutical composition for preventing or treating otitis media with effusion comprising a fraction of Melissa officinalis leaf extract.
2 . The pharmaceutical composition according to claim 1 , wherein the fraction of the extract is obtained by extracting Melissa officinalis leaves with 50 to 100% alcohol, concentrating, fractionating with ethyl acetate, and drying.
3 . The pharmaceutical composition according to claim 1 , wherein the fraction of Melissa officinalis leaf extract is an ethyl acetate fraction of ethanol extract of Melissa officinalis leaves.
4 . A method for preventing or treating otitis media with effusion, the method comprising:
administering to a subject in need thereof a therapeutically effective amount of the pharmaceutical composition comprising the fraction of Melissa officinalis leaf extract according to claim 1 .
5 - 6 . (canceled)
7 . The method composition according to claim 4 , wherein the fraction of the extract is obtained by extracting Melissa officinalis leaves with 50 to 100% alcohol, concentrating, fractionating with ethyl acetate, and drying.
8 . The method according to claim 4 , wherein the fraction of Melissa officinalis leaf extract is an ethyl acetate fraction of ethanol extract of Melissa officinalis leaves.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.